Quantcast

Latest Diabetic foot Stories

2009-12-15 09:01:00

ROSH HA'AYIN, Israel, December 15 /PRNewswire/ -- EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for the advanced chronic wound management market, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its new SilverStream(TM) solution for prescription use. The FDA also cleared DermaSept, an Over-the-Counter version of the SilverStream product. EnzySurge is the developer of the DermaStream(R) product line. DermaStream...

2009-12-03 09:00:00

NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com ), spoke at a conference on High-Risk Diabetic Foot Care in New Delhi, India, November 22, 2009. Beike is China's leading stem cell research and regenerative medicine company. The conference, organized by the Indian Podiatry Association (IPA), aimed to help podiatrists and researchers with an interest in foot disease...

2009-12-01 07:30:00

FORT WORTH, Texas, Dec. 1 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that further positive case study data on CellerateRx®, the core product of the Wound Care Innovations, LLC operating subsidiary, was released at the recent 6(th) Annual High Risk Diabetic Foot Conference for VA Podiatrists and Healthcare Professional in Tempe, AZ. One of the Wound...

2009-10-23 12:17:00

ADDISON, Texas, Oct. 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas. Highlights of the clinical experience presented by Dr. Bohn's poster presentations include: A stagnated traumatic wound that was...

2009-10-15 08:00:00

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced the publication of positive findings from the open label multi-center Phase 1/2 clinical study of Excellarate(TM) (GAM501, Ad5PDGF-B / 2.6% collagen), its product candidate for the potential treatment of non-healing diabetic foot ulcers. The clinical findings, entitled Treatment of Nonhealing Diabetic Foot Ulcers with a Platelet-Derived Growth Factor Gene-Activated Matrix (GAM501):...

2009-10-14 08:04:00

SAN DIEGO, Oct. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans for the commercial development of a new product candidate Excellagen(TM), a collagen-based topical gel for use by physicians in conjunction with surgical debridement of wounds in patients with chronic or non-chronic diabetic foot ulcers. This new product opportunity is based on clinical study findings reported today from the Excellarate(TM) Phase 2b clinical study. As reported,...

2009-09-22 20:00:00

IRVINE, Calif., Sept. 22 /PRNewswire/ -- Monarch Labs LLC, the exclusive supplier of Medical Maggots(TM) in the United States, announced today that its Laboratory Director and co-founder, Dr. Ronald Sherman, will attend the Diabetic Limb Salvage conference in Washington, DC, from September 24 to September 26. At Monarch's table display, Dr. Sherman will exhibit the company's Medical Maggots(TM) product (disinfected Phaenicia sericata larvae) and demonstrate this natural therapy to meeting...

2009-09-21 08:00:00

FORT WORTH, Texas, Sept. 21 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today its subsidiary Wound Care Innovations, LLC, will exhibit at the Georgetown University Hospital's Team Approach to Diabetic Limb Salvage (DLS) conference in Washington, D.C. September 24th-26th. The conference, focused on diabetic foot and limb salvage, is expected to be attended by more than 1,000...

2009-09-16 09:00:00

BEIJING, Sept. 16 /PRNewswire-Asia/ -- Fortis Healthcare, one of India's leading private hospital groups, has announced it will broaden inclusion criteria for its upcoming diabetic foot clinical trial. The study will use stem cells derived from peripheral blood to treat critical limb ischemia (diabetic foot). Current treatment of diabetic foot ulcers involves intensive wound management, risk reduction and lengthy rehabilitation. The current treatments available for diabetic foot are both...

2009-08-27 09:00:00

SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO) As reported in the Journal of the American Academy of Physician Assistants, (JAAPA, August 2009), chronic wounds affect an estimated 5.7 million patients...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.